CEA (CARCINO EMBRYONIC ANTIGEN)

CEA (Carcino‑embryonic Antigen) is a blood test that measures levels of a tumor‑associated protein used primarily to monitor colorectal and certain other cancers; it is not diagnostic on its own but is valuable for assessing treatment response and detecting recurrence. This at‑home CEA service offers convenient sample collection across Dubai and the UAE with processing by accredited laboratories for fast, reliable reporting—suitable for postoperative surveillance, ongoing therapy monitoring, or follow‑up in high‑risk patients. Typically no fasting is required, though smoking and some benign conditions can raise CEA levels, so results should be reviewed and interpreted by your treating physician within the UAE healthcare system.

• Carcinoembryonic Antigen (CEA)
• Quantitative CEA level (ng/mL)
• Serum sample — venous blood (home phlebotomy)
• Indication: cancer monitoring and recurrence surveillance (colorectal & other adenocarcinomas)
• Accredited UAE lab reporting — results typically in 24–48 hrs

• Sensitive tumor marker primarily used for monitoring colorectal cancer and other adenocarcinomas
• At‑home venous blood collection by certified phlebotomists available across Dubai and the UAE
• Fast testing in accredited UAE labs with numeric CEA result and standard reference range
• Suitable for baseline measurement, post‑treatment surveillance and recurrence monitoring
• Not a standalone diagnostic—results should be interpreted alongside clinical assessment by your physician

• Quantitative CEA blood test for monitoring colorectal and other epithelial cancers
• Convenient at-home sample collection by trained phlebotomists across Dubai and the UAE
• Processed in UAE-accredited laboratories using high-sensitivity assays for reliable results
• Designed for tracking treatment response and early detection of recurrence rather than standalone screening
• Secure, clinician-ready electronic report with reference ranges and guidance for follow-up

• At-home venous blood collection by certified phlebotomists across Dubai and the UAE for accurate CEA measurement
• Designed for monitoring colorectal and other CEA‑related cancers to assess treatment response and detect recurrence
• Results from accredited partner labs delivered securely online, typically within 24–48 hours
• No special fasting required; notify your clinician if you smoke, are pregnant, or recently had surgery, as these can affect CEA levels